381 related articles for article (PubMed ID: 22847439)
1. Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
Leontieva OV; Natarajan V; Demidenko ZN; Burdelya LG; Gudkov AV; Blagosklonny MV
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13314-8. PubMed ID: 22847439
[TBL] [Abstract][Full Text] [Related]
2. MEK drives cyclin D1 hyperelevation during geroconversion.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Cell Death Differ; 2013 Sep; 20(9):1241-9. PubMed ID: 23852369
[TBL] [Abstract][Full Text] [Related]
3. DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence.
Leontieva OV; Blagosklonny MV
Aging (Albany NY); 2010 Dec; 2(12):924-35. PubMed ID: 21212465
[TBL] [Abstract][Full Text] [Related]
4. Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion.
Leontieva OV; Blagosklonny MV
Oncotarget; 2014 Dec; 5(24):12715-27. PubMed ID: 25587030
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin, proliferation and geroconversion to senescence.
Blagosklonny MV
Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
[TBL] [Abstract][Full Text] [Related]
6. Elimination of proliferating cells unmasks the shift from senescence to quiescence caused by rapamycin.
Leontieva OV; Demidenko ZN; Gudkov AV; Blagosklonny MV
PLoS One; 2011; 6(10):e26126. PubMed ID: 22022534
[TBL] [Abstract][Full Text] [Related]
7. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Korotchkina LG; Leontieva OV; Bukreeva EI; Demidenko ZN; Gudkov AV; Blagosklonny MV
Aging (Albany NY); 2010 Jun; 2(6):344-52. PubMed ID: 20606252
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical suppression of cellular senescence by p53.
Demidenko ZN; Korotchkina LG; Gudkov AV; Blagosklonny MV
Proc Natl Acad Sci U S A; 2010 May; 107(21):9660-4. PubMed ID: 20457898
[TBL] [Abstract][Full Text] [Related]
9. Weak p53 permits senescence during cell cycle arrest.
Leontieva OV; Gudkov AV; Blagosklonny MV
Cell Cycle; 2010 Nov; 9(21):4323-7. PubMed ID: 21051933
[TBL] [Abstract][Full Text] [Related]
10. Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program).
Leontieva OV; Demidenko ZN; Blagosklonny MV
Oncotarget; 2015 Sep; 6(27):23238-48. PubMed ID: 26177051
[TBL] [Abstract][Full Text] [Related]
11. Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells.
Leontieva OV; Lenzo F; Demidenko ZN; Blagosklonny MV
Cell Cycle; 2012 Dec; 11(24):4642-9. PubMed ID: 23187803
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between p21 and Akt is required for p53-dependent cellular senescence.
Kim YY; Jee HJ; Um JH; Kim YM; Bae SS; Yun J
Aging Cell; 2017 Oct; 16(5):1094-1103. PubMed ID: 28691365
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia and gerosuppression: the mTOR saga continues.
Leontieva OV; Blagosklonny MV
Cell Cycle; 2012 Nov; 11(21):3926-31. PubMed ID: 22987149
[TBL] [Abstract][Full Text] [Related]
14. Persistent p21 expression after Nutlin-3a removal is associated with senescence-like arrest in 4N cells.
Shen H; Maki CG
J Biol Chem; 2010 Jul; 285(30):23105-14. PubMed ID: 20489208
[TBL] [Abstract][Full Text] [Related]
15. CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion.
Leontieva OV; Blagosklonny MV
Cell Cycle; 2013 Sep; 12(18):3063-9. PubMed ID: 23974099
[TBL] [Abstract][Full Text] [Related]
16. Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8832-7. PubMed ID: 24889617
[TBL] [Abstract][Full Text] [Related]
17. Activation of p53 with Nutlin-3a radiosensitizes lung cancer cells via enhancing radiation-induced premature senescence.
Luo H; Yount C; Lang H; Yang A; Riemer EC; Lyons K; Vanek KN; Silvestri GA; Schulte BA; Wang GY
Lung Cancer; 2013 Aug; 81(2):167-73. PubMed ID: 23683497
[TBL] [Abstract][Full Text] [Related]
18. Suppression of replicative senescence by rapamycin in rodent embryonic cells.
Pospelova TV; Leontieva OV; Bykova TV; Zubova SG; Pospelov VA; Blagosklonny MV
Cell Cycle; 2012 Jun; 11(12):2402-7. PubMed ID: 22672902
[TBL] [Abstract][Full Text] [Related]
19. S6K in geroconversion.
Leontieva OV; Demidenko ZN; Blagosklonny MV
Cell Cycle; 2013 Oct; 12(20):3249-52. PubMed ID: 24036549
[TBL] [Abstract][Full Text] [Related]
20. Cellular quiescence caused by the Mdm2 inhibitor nutlin-3A.
Korotchkina LG; Demidenko ZN; Gudkov AV; Blagosklonny MV
Cell Cycle; 2009 Nov; 8(22):3777-81. PubMed ID: 19855165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]